Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Net Tangible Assets

As of the most recent data (June 2026), DMAQR shows a net tangible assets of $2.1M. That compares with $4.3M in the prior-year period — down 52.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAQR's net tangible assets is now $2.1M (was $4.3M) — a 52.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Deep Medicine Acquisition - Tradeable Rights - Oct 2026 is outperforming or lagging.

Tracking DMAQR's net tangible assets over time shows whether Deep Medicine Acquisition - Tradeable Rights - Oct 2026 is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1M That compares with $4.3M in the prior-year period — down 52.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Deep Medicine Acquisition - Tradeable Rights - Oct 2026's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $2.1M) with ownership activity and broader fundamentals.